Non-silencing selectable marker genes and methods of use
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsMark A. Kay, Jiamiao Lu
Life of this patent
Estimating the term…
Loading patent…
AssigneeThe Board of Trustees of the Leland Stanford Junior University
InventorsMark A. Kay, Jiamiao Lu
Estimating the term…
Provided are nucleic acids and expression vectors having a non-silencing selectable marker gene, and methods of using the same. A subject expression vector includes an expression cassette and a non-silencing selectable marker gene. In some cases, the non-silencing selectable marker gene provides for drug resistance for prokaryotic cells, and includes a nucleotide sequence that (i) encodes a drug selectable marker protein; (ii) is operably linked to a promoter functional in prokaryotic cells, and (iii) includes an increased A/T content relative to a corresponding wild type nucleotide sequence. In some cases, the non-silencing selectable marker gene provides for drug resistance for prokaryotic cells, and includes a nucleotide sequence that (i) encodes a drug selectable marker protein; (ii) is operably linked to a promoter functional in prokaryotic cells, and (iii) has an A/T content in a range of from 52% to 70%.
An expression vector for transgene expression in eukaryotic cells, comprising:
An expression vector for transgene expression in eukaryotic cells, comprising:
A nucleic acid encoding a drug selectable marker protein, comprising:
Dependencies are inferred from the claim text.